Company Search:
Advanced Search
Sponsored Links
Enorama Pharma AB Company Snapshot
Enorama Pharma AB operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enorama Pharma AB with three other pharmaceutical manufacturers in Europe: Oasmia Pharmaceutical AB (2018 sales of 3.17 million Swedish Kronor [US$338,734.41 ] of which 75% was Royalty revenues), Integumen PLC of the United Kingdom (£274,000.00 [US$342,927.44 ] ), and OptiBiotix Health PLC which is also based in the United Kingdom (£514,289.00 [US$643,663.54 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Enorama Pharma AB
  Stock Performance Chart for Enorama Pharma AB
  Stock Data: Recent Stock Performance:
  Current Price (7/12/2019): 39.10
(Figures in Swedish Kronor)
1 Week 11.4%   13 Weeks 7.9%  
4 Weeks -38.5%   52 Weeks -51.0%  
Enorama Pharma AB Key Data:
  Ticker: ERMA Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 5,256,011
(Year Ending Jan 2019).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 207,173,774
  Fiscal Yr Ends: December Shares Outstanding: 5,298,562
  Share Type: AKTIE Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.